Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Rebekah Christensen, AAAOM Ed
Rebekah Christensen is the executive director of the AAAOM and past executive director of the California State Oriental Medical Association.